CONMED Corporation (CNMD)
USD 48.33
(0.62%)
USD 48.33
(0.62%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 318.32 Million USD | -4.21% |
| 2022 | 332.32 Million USD | 43.46% |
| 2021 | 231.64 Million USD | 18.87% |
| 2020 | 194.86 Million USD | 18.38% |
| 2019 | 164.61 Million USD | 6.48% |
| 2018 | 154.59 Million USD | 9.31% |
| 2017 | 141.43 Million USD | 4.1% |
| 2016 | 135.86 Million USD | -18.59% |
| 2015 | 166.89 Million USD | 12.65% |
| 2014 | 148.14 Million USD | 3.45% |
| 2013 | 143.21 Million USD | -8.33% |
| 2012 | 156.22 Million USD | -7.25% |
| 2011 | 168.43 Million USD | -2.52% |
| 2010 | 172.79 Million USD | 5.19% |
| 2009 | 164.27 Million USD | 2.69% |
| 2008 | 159.97 Million USD | -3.03% |
| 2007 | 164.96 Million USD | 8.76% |
| 2006 | 151.68 Million USD | -0.49% |
| 2005 | 152.42 Million USD | 19.14% |
| 2004 | 127.93 Million USD | 5.78% |
| 2003 | 120.94 Million USD | 0.42% |
| 2002 | 120.44 Million USD | 12.15% |
| 2001 | 107.39 Million USD | 2.66% |
| 2000 | 104.61 Million USD | 16.62% |
| 1999 | 89.7 Million USD | 14.85% |
| 1998 | 78.1 Million USD | 34.89% |
| 1997 | 57.9 Million USD | 149.57% |
| 1996 | 23.2 Million USD | 11.0% |
| 1995 | 20.9 Million USD | 117.71% |
| 1994 | 9.6 Million USD | 6.67% |
| 1993 | 9 Million USD | 0.0% |
| 1992 | 9 Million USD | 28.57% |
| 1991 | 7 Million USD | 62.79% |
| 1990 | 4.3 Million USD | -25.86% |
| 1989 | 5.8 Million USD | 61.11% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 322.35 Million USD | 0.02% |
| 2024 Q3 | 342.55 Million USD | 6.26% |
| 2024 Q1 | 322.29 Million USD | 1.25% |
| 2023 Q2 | 327.3 Million USD | -2.4% |
| 2023 Q1 | 335.37 Million USD | 0.92% |
| 2023 Q3 | 325.82 Million USD | -0.45% |
| 2023 Q4 | 318.32 Million USD | -2.3% |
| 2023 FY | 318.32 Million USD | -4.21% |
| 2022 Q3 | 304.81 Million USD | 5.21% |
| 2022 FY | 332.32 Million USD | 43.46% |
| 2022 Q2 | 289.71 Million USD | 14.18% |
| 2022 Q4 | 332.32 Million USD | 9.02% |
| 2022 Q1 | 253.72 Million USD | 9.53% |
| 2021 Q3 | 228.57 Million USD | 8.16% |
| 2021 FY | 231.64 Million USD | 18.87% |
| 2021 Q1 | 205.79 Million USD | 5.61% |
| 2021 Q2 | 211.32 Million USD | 2.69% |
| 2021 Q4 | 231.64 Million USD | 1.34% |
| 2020 Q4 | 194.86 Million USD | 6.68% |
| 2020 FY | 194.86 Million USD | 18.38% |
| 2020 Q3 | 182.66 Million USD | 3.96% |
| 2020 Q2 | 175.71 Million USD | 0.67% |
| 2020 Q1 | 174.53 Million USD | 6.03% |
| 2019 FY | 164.61 Million USD | 6.48% |
| 2019 Q3 | 173.92 Million USD | 0.65% |
| 2019 Q4 | 164.61 Million USD | -5.35% |
| 2019 Q2 | 172.8 Million USD | 1.0% |
| 2019 Q1 | 171.08 Million USD | 10.67% |
| 2018 Q3 | 153.61 Million USD | 7.12% |
| 2018 FY | 154.59 Million USD | 9.31% |
| 2018 Q1 | 145.78 Million USD | 3.08% |
| 2018 Q2 | 143.4 Million USD | -1.63% |
| 2018 Q4 | 154.59 Million USD | 0.64% |
| 2017 Q4 | 141.43 Million USD | -5.42% |
| 2017 Q2 | 136.47 Million USD | -2.58% |
| 2017 Q1 | 140.08 Million USD | 3.1% |
| 2017 Q3 | 149.53 Million USD | 9.57% |
| 2017 FY | 141.43 Million USD | 4.1% |
| 2016 Q1 | 185.1 Million USD | 10.91% |
| 2016 Q3 | 188.52 Million USD | 4.79% |
| 2016 Q2 | 179.91 Million USD | -2.81% |
| 2016 FY | 135.86 Million USD | -18.59% |
| 2016 Q4 | 135.86 Million USD | -27.93% |
| 2015 Q2 | 149.18 Million USD | 3.45% |
| 2015 FY | 166.89 Million USD | 12.65% |
| 2015 Q1 | 144.19 Million USD | -2.67% |
| 2015 Q4 | 166.89 Million USD | 3.3% |
| 2015 Q3 | 161.55 Million USD | 8.3% |
| 2014 FY | 148.14 Million USD | 3.45% |
| 2014 Q4 | 148.14 Million USD | -8.61% |
| 2014 Q1 | 152.17 Million USD | 6.26% |
| 2014 Q2 | 157 Million USD | 3.18% |
| 2014 Q3 | 162.09 Million USD | 3.24% |
| 2013 Q3 | 150.99 Million USD | 1.53% |
| 2013 Q4 | 143.21 Million USD | -5.16% |
| 2013 Q2 | 148.71 Million USD | -5.2% |
| 2013 Q1 | 156.87 Million USD | 0.41% |
| 2013 FY | 143.21 Million USD | -8.33% |
| 2012 Q4 | 156.22 Million USD | -5.5% |
| 2012 FY | 156.22 Million USD | -7.25% |
| 2012 Q2 | 159.15 Million USD | -2.59% |
| 2012 Q1 | 163.39 Million USD | -3.0% |
| 2012 Q3 | 165.32 Million USD | 3.88% |
| 2011 Q3 | 174.79 Million USD | 3.27% |
| 2011 Q1 | 171.21 Million USD | -0.92% |
| 2011 Q2 | 169.25 Million USD | -1.14% |
| 2011 Q4 | 168.43 Million USD | -3.64% |
| 2011 FY | 168.43 Million USD | -2.52% |
| 2010 Q2 | 170.81 Million USD | 1.3% |
| 2010 Q4 | 172.79 Million USD | -5.73% |
| 2010 Q1 | 168.61 Million USD | 2.64% |
| 2010 Q3 | 183.3 Million USD | 7.31% |
| 2010 FY | 172.79 Million USD | 5.19% |
| 2009 FY | 164.27 Million USD | 2.69% |
| 2009 Q3 | 164.92 Million USD | 1.81% |
| 2009 Q4 | 164.27 Million USD | -0.4% |
| 2009 Q2 | 161.99 Million USD | 1.35% |
| 2009 Q1 | 159.83 Million USD | -0.09% |
| 2008 Q4 | 159.97 Million USD | -0.88% |
| 2008 Q3 | 161.4 Million USD | 0.21% |
| 2008 Q2 | 161.05 Million USD | -2.16% |
| 2008 FY | 159.97 Million USD | -3.03% |
| 2008 Q1 | 164.61 Million USD | -0.22% |
| 2007 Q4 | 164.96 Million USD | -1.05% |
| 2007 FY | 164.96 Million USD | 8.76% |
| 2007 Q1 | 153.84 Million USD | 1.42% |
| 2007 Q2 | 161.81 Million USD | 5.19% |
| 2007 Q3 | 166.71 Million USD | 3.02% |
| 2006 Q2 | 153.66 Million USD | -2.58% |
| 2006 Q3 | 154.7 Million USD | 0.68% |
| 2006 Q4 | 151.68 Million USD | -1.95% |
| 2006 FY | 151.68 Million USD | -0.49% |
| 2006 Q1 | 157.73 Million USD | 3.48% |
| 2005 Q2 | 142.05 Million USD | 7.6% |
| 2005 FY | 152.42 Million USD | 19.14% |
| 2005 Q4 | 152.42 Million USD | 0.09% |
| 2005 Q1 | 132.01 Million USD | 3.19% |
| 2005 Q3 | 152.29 Million USD | 7.21% |
| 2004 FY | 127.93 Million USD | 5.78% |
| 2004 Q1 | 115.21 Million USD | -4.74% |
| 2004 Q2 | 116.09 Million USD | 0.76% |
| 2004 Q3 | 130.74 Million USD | 12.62% |
| 2004 Q4 | 127.93 Million USD | -2.15% |
| 2003 FY | 120.94 Million USD | 0.42% |
| 2003 Q2 | 128.3 Million USD | 2.05% |
| 2003 Q1 | 125.72 Million USD | 4.38% |
| 2003 Q4 | 120.94 Million USD | -5.2% |
| 2003 Q3 | 127.58 Million USD | -0.56% |
| 2002 Q4 | 120.44 Million USD | 2.17% |
| 2002 Q1 | 109.95 Million USD | 2.38% |
| 2002 FY | 120.44 Million USD | 12.15% |
| 2002 Q2 | 114.86 Million USD | 4.47% |
| 2002 Q3 | 117.88 Million USD | 2.62% |
| 2001 FY | 107.39 Million USD | 2.66% |
| 2001 Q4 | 107.39 Million USD | 0.05% |
| 2001 Q3 | 107.33 Million USD | 4.01% |
| 2001 Q2 | 103.19 Million USD | -1.22% |
| 2001 Q1 | 104.47 Million USD | -0.13% |
| 2000 FY | 104.61 Million USD | 16.62% |
| 2000 Q2 | 96.47 Million USD | 6.04% |
| 2000 Q3 | 104.97 Million USD | 8.81% |
| 2000 Q4 | 104.61 Million USD | -0.34% |
| 2000 Q1 | 90.97 Million USD | 1.42% |
| 1999 Q2 | 87.9 Million USD | 6.55% |
| 1999 Q3 | 94.4 Million USD | 7.39% |
| 1999 Q4 | 89.7 Million USD | -4.98% |
| 1999 FY | 89.7 Million USD | 14.85% |
| 1999 Q1 | 82.5 Million USD | 5.63% |
| 1998 Q3 | 74.1 Million USD | 7.7% |
| 1998 Q4 | 78.1 Million USD | 5.4% |
| 1998 FY | 78.1 Million USD | 34.89% |
| 1998 Q1 | 60.7 Million USD | 4.84% |
| 1998 Q2 | 68.8 Million USD | 13.34% |
| 1997 Q4 | 57.9 Million USD | 147.44% |
| 1997 FY | 57.9 Million USD | 149.57% |
| 1997 Q1 | 21.8 Million USD | -6.03% |
| 1997 Q2 | 22.8 Million USD | 4.59% |
| 1997 Q3 | 23.4 Million USD | 2.63% |
| 1996 FY | 23.2 Million USD | 11.0% |
| 1996 Q1 | 24.2 Million USD | 15.79% |
| 1996 Q2 | 24.4 Million USD | 0.83% |
| 1996 Q3 | 23 Million USD | -5.74% |
| 1996 Q4 | 23.2 Million USD | 0.87% |
| 1995 FY | 20.9 Million USD | 117.71% |
| 1995 Q2 | 19.6 Million USD | 20.99% |
| 1995 Q3 | 20.5 Million USD | 4.59% |
| 1995 Q4 | 20.9 Million USD | 1.95% |
| 1995 Q1 | 16.2 Million USD | 68.75% |
| 1994 Q4 | 9.6 Million USD | -2.04% |
| 1994 Q1 | 9.2 Million USD | 2.22% |
| 1994 Q2 | 9.7 Million USD | 5.43% |
| 1994 Q3 | 9.8 Million USD | 1.03% |
| 1994 FY | 9.6 Million USD | 6.67% |
| 1993 Q4 | 9 Million USD | -16.67% |
| 1993 Q3 | 10.8 Million USD | 16.13% |
| 1993 Q1 | 9.1 Million USD | 1.11% |
| 1993 FY | 9 Million USD | 0.0% |
| 1993 Q2 | 9.3 Million USD | 2.2% |
| 1992 Q2 | 8.4 Million USD | 10.53% |
| 1992 Q4 | 9 Million USD | -2.17% |
| 1992 Q1 | 7.6 Million USD | 8.57% |
| 1992 FY | 9 Million USD | 28.57% |
| 1992 Q3 | 9.2 Million USD | 9.52% |
| 1991 Q2 | 5.7 Million USD | 11.76% |
| 1991 Q3 | 6.3 Million USD | 10.53% |
| 1991 FY | 7 Million USD | 62.79% |
| 1991 Q4 | 7 Million USD | 11.11% |
| 1991 Q1 | 5.1 Million USD | 18.6% |
| 1990 Q3 | 4.3 Million USD | -14.0% |
| 1990 Q1 | 5.3 Million USD | -8.62% |
| 1990 Q4 | 4.3 Million USD | 0.0% |
| 1990 FY | 4.3 Million USD | -25.86% |
| 1990 Q2 | 5 Million USD | -5.66% |
| 1989 Q3 | 7 Million USD | 0.0% |
| 1989 Q4 | 5.8 Million USD | -17.14% |
| 1989 FY | 5.8 Million USD | 61.11% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Abbott Laboratories | 6.57 Billion USD | 95.155% |
| Allurion Technologies Inc. | 6.17 Million USD | -5058.386% |
| Artivion, Inc. | 81.97 Million USD | -288.314% |
| Avanos Medical, Inc. | 163.2 Million USD | -95.051% |
| Butterfly Network, Inc. | 75.83 Million USD | -319.748% |
| Butterfly Network, Inc. | 75.83 Million USD | -319.748% |
| Bio-Rad Laboratories, Inc. | 780.51 Million USD | 59.216% |
| Boston Scientific Corporation | 2.48 Billion USD | 87.185% |
| Edwards Lifesciences Corporation | 1.16 Billion USD | 72.751% |
| Paragon 28, Inc. | 98.06 Million USD | -224.615% |
| Glaukos Corporation | 41.98 Million USD | -658.167% |
| Globus Medical, Inc. | 848.13 Million USD | 62.468% |
| Inspire Medical Systems, Inc. | 33.88 Million USD | -839.425% |
| Integer Holdings Corporation | 239.71 Million USD | -32.792% |
| Medtronic plc | 5.21 Billion USD | 93.898% |
| Myomo, Inc. | 1.8 Million USD | -17550.278% |
| Nevro Corp. | 118.67 Million USD | -168.229% |
| Owlet, Inc. | 6.49 Million USD | -4802.572% |
| Penumbra, Inc. | 388.02 Million USD | 17.963% |
| Vicarious Surgical Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 2.39 Billion USD | 86.709% |
| Sonendo, Inc. | 11.07 Million USD | -2774.517% |
| STERIS plc | 674.53 Million USD | 52.808% |
| Stryker Corporation | 4.84 Billion USD | 93.427% |
| Vapotherm, Inc. | 22.96 Million USD | -1285.946% |
| Zimmer Biomet Holdings, Inc. | 2.38 Billion USD | 86.654% |